Trial Profile
Interdisciplinary Study of Two Novel Anticonvulsants in Alcoholism
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 May 2023
Price :
$35
*
At a glance
- Drugs Zonisamide (Primary)
- Indications Alcoholism
- Focus Therapeutic Use
- 25 Apr 2022 Status changed from recruiting to completed.
- 07 Mar 2022 Planned End Date changed from 1 Aug 2021 to 1 Aug 2023.
- 07 Mar 2022 Planned primary completion date changed from 1 Feb 2021 to 1 Feb 2023.